로딩 중…
지수 로딩 중…
Allogene Therapeutics, Inc.
ALLO· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$2.00+2.04%
2026-06-18
Price Chart
Allogene Therapeutics, Inc.+55.04%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $690M |
| Revenue | $0.00 |
| Net Income | $-174M |
| Total Assets | $396M |
| Net Assets | $279M |
| Value | |
| P/B | 2.48x |
| FCF Yield | -15.87% |
| Profitability | |
| ROE | -62.31% |
| ROA | -43.88% |
| Revenue Growth | -100.00% |
| Financial Health | |
| Debt Ratio | 41.98% |
| Total Debt | $81M |
| FCF | $-110M |
| Cash | $30M |
| Current Ratio | 9.65x |
| Performance | |
| 1Y Return | 55.04% |
| 1M Return | 5.82% |
| From 52W High | -55.16% |
| 1Y MDD | -41.83% |
| Trading | |
| Volume | 16,453,079 shares |
| Trading Value | $33M |
| Per Share | |
| EPS | $-0.87 |
| BPS | $1.33 |